Cytotheryx Secures $60M Series A, Confirms Debt to Expand Facilities
Cytotheryx’s Series A financing, alongside strategic debt funding, will advance its cell therapy programs toward clinical development and support GMP manufacturing scale-up. Cytotheryx, Inc. , a...